Oura announced a comprehensive redesign of its companion app alongside new health tracking capabilities that push beyond basic activity monitoring. The updates include a restructured interface, enhanced cycle tracking, and a new approach to measuring long-term stress impact.
Three-Tab Architecture
The redesigned app consolidates health data into three primary sections. The Today tab surfaces a single priority insight—what Oura calls "One Big Thing"—alongside secondary metrics for quick decision-making. Vitals provides time-scaled views of sleep, stress, and cardiovascular data ranging from daily snapshots to multi-year trends. My Health aggregates long-term patterns and includes access to Oura Advisor, the company's AI-powered analysis tool.
The interface now uses color shifts tied to biometric changes, allowing users to assess their status without parsing numerical data. This visual feedback system operates across all three tabs.
Cumulative Stress Measurement
Unlike typical stress tracking that captures discrete moments, Oura's new Cumulative Stress feature analyzes how the body accumulates and processes stress over 30-day periods. The metric updates weekly and synthesizes five physiological markers:
- Sleep continuity patterns
- Heart rate and heart rate variability post-stress response
- Sleep micromotions (subtle movements including twitches)
- Overnight temperature regulation
- Activity impact on recovery
Jason Russell, Oura's VP of Consumer Software Product, emphasized that the system measures stress through bodily responses rather than simply logging stressful periods. The feature identifies physiological signatures that indicate chronic stress is affecting the body's regulatory systems.
Enhanced Menstrual Cycle Tracking
Cycle prediction capabilities now extend to a 12-month view, up from the previous single-month window. More significantly, the updated system can generate cycle phase predictions from a single night of sleep data rather than requiring a full month of information before providing insights.
Blood Pressure Research Initiative
Oura is launching a Blood Pressure Profile study through its experimental Oura Labs platform, targeting FDA clearance for hypertension detection. The study received Institutional Review Board approval and will roll out to U.S. users later this year.
Participants receive a hypertension likelihood assessment that combines passive ring data with responses to a questionnaire covering family history, medications, and lifestyle factors. The system classifies users into three categories: no signs, moderate signs, or major signs of hypertension. Those showing strong indicators will receive prompts to seek medical evaluation. The algorithm tracks changes longitudinally and triggers periodic reassessments throughout the study period.
Availability and Context
The app redesign deploys globally over the coming weeks on both iOS and Android. Oura noted that its Android development team has expanded, which should improve cross-device stability and functionality.
These announcements follow Oura's recent $900 million funding round led by Fidelity Management & Research, the launch of the Ring 4 Ceramic collection, and the introduction of Health Panels—a feature enabling direct blood work scheduling through the app.
The updates position Oura beyond standard fitness tracking toward clinical-grade health monitoring, with the blood pressure research representing a significant step into diagnostic territory pending regulatory approval.
Discussion